<DOC>
	<DOCNO>NCT01782131</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy posaconazole versus voriconazole treatment adult adolescent invasive aspergillosis ( IA ) .</brief_summary>
	<brief_title>A Study Safety Efficacy Posaconazole Versus Voriconazole Treatment Invasive Aspergillosis ( MK-5592-069 )</brief_title>
	<detailed_description />
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<mesh_term>Posaconazole</mesh_term>
	<criteria>Weight &gt; 40 kg ( 88 lb ) â‰¤150 kg ( 330 lb ) ; 13 14 year age must weigh &gt; = 50 kg ( 110 lb ) Acute IA define duration clinical syndrome &lt; 30 day . Female subject childbearing potential must use medically accept method birth control begin studydrug treatment agree continue use 30 day stop study medication . Chronic ( &gt; 1 month duration ) IA , relapsed/recurrent IA , refractory IA respond antifungal therapy . Chronic pulmonary aspergillosis , pulmonary sarcoidosis , aspergilloma , allergic bronchopulmonary aspergillosis ( ABPA ) . Known mixed invasive mold fungal infection include Zygomycetes , and/or know invasive Aspergillus fungal infection either study drug may consider active . Receipt systemic ( oral , intravenous , inhale ) antifungal therapy infection episode 4 consecutive day ( &gt; = 96 hour ) immediately randomization . Developed current episode IA infection receipt &gt; 13 day antifungal prophylaxis agent consider moldactive antifungal agent . Receipt posaconazole voriconazole empirical treatment infection 4 day ( 96 hour ) within 15 day immediately randomization . Known hypersensitivity serious adverse reaction azole antifungal therapy ingredient study medication use . Females pregnant , intend become pregnant , nursing time randomization . Known history Torsade de Pointes , unstable cardiac arrhythmia proarrhythmic condition , history recent myocardial infarction within 90 day study entry . Hepatic cirrhosis ChildPugh score C ( severe hepatic impairment ) time randomization . Severe renal insufficiency ( estimate creatinine clearance &lt; 20 mL/min ) hemodialysis time randomization likely require dialysis study . Known hereditary problem galactose intolerance , Lapp lactase deficiency , glucosegalactose malabsorption . Acute symptomatic pancreatitis within 6 month study entry diagnosis chronic pancreatitis time randomization . Active skin lesion consistent squamous cell carcinoma time randomization , current prior history malignant melanoma within 5 year study entry . On artificial ventilation receive acute Continuous Positive Airway Pressure ( CPAP ) /Bilevel Positive Airway Pressure ( BPAP ) time randomization . Known suspect Gilbert 's disease time randomization . Requires treatment medication stop know contraindication coadministration one study drug .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>